Progress in cardiovascular gene therapy has been hampered by concerns over the safety and practicality of viral vectors and the inefficiency of current nonviral transfection techniques. We have previously reported that ultrasound exposure (USE) enhances transgene expression in vascular cells by up to 10-fold after naked DNA transfection, and enhances lipofection by up to three-fold. We report here that performing USE in the presence of microbubble echocontrast agents enhances acoustic cavitation and is associated with approximately 300-fold increments in transgene
Progress in cardiovascular gene therapy has been hampered by concerns over the safety and practicality of viral vectors and the inefficiency of current nonviral transfection techniques. We have previously reported that ultrasound exposure (USE) enhances transgene expression in vascular cells by up to 10-fold after naked DNA transfection, and enhances lipofection by up to three-fold. We report here that performing USE in the presence of microbubble echocontrast agents enhances acoustic cavitation and is associated with approximately 300-fold increments in transgene Keywords: ultrasound; microbubbles; transfection; cavitation; vascular; restenosis Gene therapy approaches have been investigated for a number of difficult clinical problems in cardiovascular medicine, most notably the prevention of angioplasty restenosis and amelioration of intractable myocardial or peripheral ischaemia. 1 Angioplasty restenosis occurs in 10-60% of patients depending upon the vessel treated and represents the end result of a healing response to vascular injury which involves both vessel shrinkage and lumen obstruction by a proliferative neointima comprising vascular smooth muscle cells (VSMC) and extracellular matrix. 2, 3 Animal studies have demonstrated that local delivery of recombinant viral vectors encoding genes which modulate VSMC and/or endothelial cell (EC) behaviour can reduce the neointimal response to experimental angioplasty. 4, 5 There are increasing concerns, however, over the safety, practicality and public acceptability of such viral vectors for clinical use, 6 particularly in the context of non-life-threatening conditions such as angioplasty restenosis. 7 As a result, there is renewed interest in the development of nonviral transfection techniques that circumvent these issues.
An essential requirement for successful transfection is the transfer of exogenous nucleic acid across the plasma membrane. Recent evidence suggests that ultrasound exposure (USE) can increase the permeability of eukaryotic cell membranes to large molecules such as high molecular weight dextrans and plasmid DNA. [8] [9] [10] [11] [12] USE also accelerates the membrane-destabilising hexagonal phase transition of dioleoyl phosphatidylcholine (DOPE), a expression after naked DNA transfections. This approach also enhances by four-fold the efficiency of polyplex transfection, yielding transgene expression levels approximately 3000-fold higher than after naked DNA alone. These data indicate an important role for acoustic cavitation in the effects of USE. Ultrasound can be focused upon almost any organ and hence this approach holds promise as a means to deliver targeted gene therapy in cardiovascular conditions such as such angioplasty restenosis and in many other clinical situations. Gene Therapy (2000) 7, 2023-2027. component of many lipofection reagents which promotes endosomal 'breakout' following DNA internalisation. 13, 14 We have previously reported that a 60 s exposure of porcine VSMC to low intensity 1 MHz ultrasound during naked plasmid transfection enhanced luciferase activity measured 48 h later by up to 10-fold. 15 Reporter gene expression following lipofection was also enhanced by two-to three-fold. This low level of USE had no effect on cell survival although cellular proliferation was reduced. Similar results have been reported in a variety of immortalised cell lines and primary cultures of nonvascular cells, supporting the general concept of ultrasoundenhanced nonviral transfection. [9] [10] [11] [16] [17] [18] [19] [20] Although encouraging, the enhancements observed in our early studies were at a level that is unlikely to be clinically relevant. To direct our efforts to improve efficiency we have begun to investigate the mechanisms underlying ultrasound-enhanced transfection, both in terms of the site(s) of action within the cell and the key characteristics of the ultrasound beam. In this regard, one of the most important of ultrasound's bioeffects is acoustic cavitation, a term which refers to the interaction between an ultrasonic field in a liquid and gaseous inclusions (ie microbubbles) within the insonated medium. 21, 22 Cavitation may be subdivided into two categories. Stable cavitation refers to the induction of stable low amplitude resonant oscillations of pre-existing microbubbles by low intensity USE, which in turn generates local shear forces and acoustic microstreaming in the adjacent fluid. As the ultrasound intensity is increased, the amplitude of oscillation also rises until the bubble becomes unstable and collapses suddenly due to the inertia of the inrushing fluid, giving rise to the term inertial cavitation. The resulting extremes of pressure and tem-perature within the collapsing bubble are sufficient to initiate free radical generation by hydrolysis of contained water vapour. Reverberation following bubble collapse also generates shock waves and their associated shear forces within the medium and, if this occurs in proximity to a fluid/solid interface (for example a cell membrane), high velocity fluid jets directed towards the solid structure.
If cavitation is indeed important, then deliberately adding further microbubbles could potentially magnify the observed effects. 23 To test this hypothesis, we examined the effects of supplementing the transfection medium before USE with Albunex or Optison, microbubble echocontrast agents used in clinical ultrasound imaging. Both comprise suspensions of albumin-stabilised microbubbles, either containing air (Albunex) or the fluorocarbon gas octafluoropropane (Optison). Including microbubbles at concentrations р10% (v/v) during transfections performed without USE had no effect on subsequent luciferase activity or cell viability (data not shown). USE was performed with a new variable-output 956 kHz transducer system configured to minimise thermal effects due to heat generation in the transducer ceramic and to provide a highly uniform ultrasound beam profile in the well plate, without standing waves ( Figure 1 ). Preliminary optimisation experiments indicated that USE for 60 s at 2.0 mechanical index (MI), 6% duty cycle, both with and without microbubbles at 10% (v/v), gave the best results without affecting temperature (data not shown) and hence these parameters were used for the majority of the studies reported here.
Luciferase activity was consistently detectable (0.64 ± 0.38 (s.e.m.) light units per microgramme total cell protein (LU/g) (range 0.2-1.5)) following transfection of primary porcine VSMC with naked plasmid (pGL3) and no USE; adjunctive USE in the absence of microbubbles was associated with a mean 16-fold increase in luciferase activity, but this enhancement did not reach statistical significance due to major variations between individual experiments ( Figure 2 ) (10.31 ± 9.63 LU/g (range 0.2-48.9)). In contrast, USE in the presence of either Albunex or Optison microbubbles resulted in similar, more than 200-fold, enhancements (137.2 ± 89.7 LU/g (range 1.6-487.9) and 128.8 ± 72.0 LU/g (range 8.7-327.9), respectively), at least equivalent to that achieved by optimised liposome-mediated transfection (82.9 ± 42.9 LU/g) using a commercial DOPE-containing lipofection reagent ( Figure 2 ).
Assays of cavitational activity per se are unsatisfactory and essentially measure individual consequences of inertial and not stable cavitation, including cell lysis (especially haemolysis), sonochemical (often hydrogen peroxide) production, and assessment of harmonic emissions consequent upon sudden bubble collapse. 24 Using an assay based upon the reaction of hydrogen peroxide (itself a surrogate for oxygen-based free radicals) with isoluminol, 25 sonochemical production was clearly detectable following USE, and was enhanced significantly in the presence of Optison (Figure 3 ). This relatively small effect of adding microbubbles (Ͻtwo-fold increase) on free radical production does not correlate with the effects on transgene expression (10-to 20-fold increase, see Figure 2 ), suggesting that there is not a simple relationship between sonochemical production (at least not those measured by this assay) and enhanced transgene expression.
Although the term 'sonoporation' has been coined to describe the effects of USE on transgene expression, 9, 11, 26 measurements of reporter gene activity cannot in isolation define the site(s) of action of ultrasound, and mechanisms other than membrane permeabilisation may also be important. 26, 27 For example, the SV40 promoterenhancer within the pGL3 luciferase plasmid contains multiple consensus sequences for binding of the transcription factor nuclear factor B (NFB). It is conceivable Figure 2 Effect of USE ± microbubbles on naked DNA transfections. VSMC were transfected with naked pGL3 DNA as described in Figure 1 Figure 1 . Cavitation was measured using an isoluminol-based assay for hydrogen peroxide. 25 that ultrasound-induced inertial cavitation could enhance reporter gene transcription through effects of free radicals to promote activation of NFB. 28 To investigate this possibility, we constructed a second plasmid (pRSVLUC) in which luciferase gene transcription is driven from the Rous sarcoma virus (RSV) promoter, that does not contain consensus sequences for NFB binding. Given the similarities between the effects of Albunex and Optison Figure 1 and in our previous experiments, and the fact that Albunex is no longer available for clinical use, subsequent studies were performed with Optison only. Luciferase activity was again detectable at low levels following control transfections with naked plasmid alone (0.3 ± 0.1 LU/g (range 0.1-0.9) for pGL3; 0.4 ± 0.2 LU/g (range 0.04-1.9) for pRSVLUC). USE in the presence of 10% (v/v) Optison produced very similar (approximately 300-fold) enhancements with pRSVLUC to those achieved in parallel experiments with the pGL3 plasmid (Figure 4a ) (110.7 ± 27.9 LU/g (range 20-254) for pGL3; 112.7 ± 33.4 LU/g (range 23-290) for pRSVLUC). USE in the presence of Optison was associated with physical detachment of approximately 40% of cells exposed by the end of the 3-h transfection period, but the remaining adherent cells demonstrated proliferation (and viability, data not shown) rates over the subsequent 48 h which were equivalent to VSMC not exposed to ultrasound (Figure 4b) .
Figure 3 Measurement of cavitation induced by USE ± microbubbles. Two hundred l PBS ± 10% (v/v) Optison was exposed to ultrasound or sham treatment for 60 s in a 24-well plate as described in
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Figure 4 (a) Effect of plasmid promoter on response to USE in the presence of Optison. VSMCs were transfected with either naked pGL3 (SV40 promoter) or pRSVLUC (RSV promoter). USE was performed as described in
In an attempt to analyse further the potential involvement of free radicals, we examined the effect of reducing the intensity of USE until hydrogen peroxide production was no longer detectable. Maintaining a duty cycle of 6% but reducing the MI to 1.1 abolished detectable hydrogen peroxide production in the presence or absence of Optison (Figure 3) , and yet was associated with luciferase activities that were statistically indistinguishable from those achieved at the higher intensity (Figure 4a ).
These data suggest that cavitational mechanisms are important contributors to the observed effects of USE, and are in agreement with studies in immortalised nonvascular cells. 9, 19, 29 Our data are also consistent with an involvement of the direct mechanical effects of cavitation in the observed effects on transgene expression. Interestingly, other investigators have reported that the relative contribution of the mechanical and sonochemical effects of inertial cavitation to the observed effects is intensitydependent. 30 The involvement of cavitation is further supported by the fact that exposure to lithotripter shock waves, which induce gallstone and kidney stone fragmentation through cavitational mechanisms, is also associated with enhanced transgene expression following naked DNA transfection in vitro. 18, 31, 32 We and others have previously reported that USE also enhances transgene expression following lipofection in vitro. 15, 17, 19 USE of porcine VSMC in the presence of Optison had no significant effect upon transgene expression following lipofection using the Promega reagent Tfx-50 according to conditions previously optimised in the absence of microbubbles or ultrasound (Figure 5a ), and indeed luciferase activity was lower than that observed with the combination of USE, Optison and naked plasmid DNA (Figures 2 and 4) . Co-operative effects may be seen using different USE or lipofection conditions, perhaps using lower intensity USE. 19 Indeed, the USE parameters used here in the presence of microbubbles may have had effects to disrupt unfavourably the interaction between plasmid DNA and lipofection reagent, which itself is produced by a method which involves sonication of lipid in suspension. We therefore investigated the effect of USE upon transgene expression following transfections using a non-lipid polyamine transfection reagent TransIT-LT1. Transfections with LT1 alone were notably more efficient than those with Tfx-50. Luciferase activity was, however, enhanced by up to a further four-fold through the use of adjunctive USE (Figure 5b ) (927 ± 359 LU/g (range 131-2820) with USE cf. 229 ± 72 LU/g (range 55-626) for pGL3 control; 669 ± 172 LU/g (range 237-1708) with USE cf. 220 ± 28 LU/g (range 150-365) for pRSVLUC control).
We have reported here that microbubble-enhanced ultrasound can achieve transgene expression levels in vitro approximately 300-fold higher than with naked plasmid DNA alone. This can be increased to approximately 3000-fold over naked DNA alone by combining this approach with a polyplex transfection reagent. The challenge is now to translate these findings safely and effectively to the in vivo setting, where transfection efficiencies are often one or more orders of magnitude less efficient. Although experience with ultrasound-enhanced gene delivery in vivo is very limited at present, Schratzberger et al 33 recently demonstrated 33-fold increases in ␤-galactosidase expression in rabbit hind limb skeletal muscle using an essentially identical transducer and USE parameters and, significantly, a demonstrable improvement in revascularisation of rabbit hind limbs following intramuscular injection of a documented subtherapeutic dose of a plasmid encoding vascular endothelial growth factor. These results were obtained without evidence of muscle damage. Tachibana et al 34 also reported significant increases in reporter gene expression in mouse quadriceps following USE at 1 MHz which was also associated with a four-fold increase in fluorescent DNA uptake. Significant enhancement of reporter gene expression in solid tumours in vivo has also been reported. 20 Although our own interest is in the use of ultrasound to promote local gene delivery at the site of angioplasty, nearly every organ system can be accessed by internally or externally focused ultrasound transducers. The present experiments were carried out with ultimate clinical applicability in mind, employing USE parameters which approximate to accepted MI and I SPPA guidelines for diagnostic transducers, 27, 35 although the duty cycles employed by ourselves and other investigators are currently greater than those used for diagnostic imaging. Although the microbubble concentrations used in this and previous studies are much higher than those achieved in clinical imaging protocols, Miller and Thomas 23 demonstrated significant enhancement of ultrasoundinduced cavitation in the presence of 0.01% (v/v) Albunex, three orders of magnitude lower than used in the present experiments and 10-fold lower than the systemic concentrations achieved during diagnostic imaging with echocontrast agents. The ability to deliver polyplex and liposome-complexed plasmid and microbubble echocon-trast agents in vivo, combined with the ability to focus ultrasound upon the relevant target, thus gives rise to the exciting prospect of using this combination to achieve efficient and yet targeted therapeutic gene delivery throughout the body.
